Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Meningioma | 38 | 2024 | 1218 | 6.770 |
Why?
|
Meningeal Neoplasms | 39 | 2024 | 1248 | 6.500 |
Why?
|
Brain Neoplasms | 57 | 2024 | 9032 | 3.300 |
Why?
|
Skull Base Neoplasms | 7 | 2024 | 270 | 2.680 |
Why?
|
Pituitary Neoplasms | 16 | 2024 | 1323 | 2.150 |
Why?
|
Radiosurgery | 6 | 2023 | 1342 | 1.520 |
Why?
|
Glioma | 23 | 2024 | 3455 | 1.470 |
Why?
|
Glioblastoma | 15 | 2024 | 3483 | 1.370 |
Why?
|
Craniopharyngioma | 4 | 2021 | 276 | 1.360 |
Why?
|
Neurosurgical Procedures | 20 | 2024 | 2072 | 1.150 |
Why?
|
Adenoma | 10 | 2021 | 2163 | 0.950 |
Why?
|
Neuroma, Acoustic | 5 | 2022 | 459 | 0.930 |
Why?
|
Neurosurgery | 4 | 2023 | 679 | 0.910 |
Why?
|
Central Nervous System Neoplasms | 4 | 2024 | 916 | 0.880 |
Why?
|
Gliosarcoma | 1 | 2021 | 114 | 0.750 |
Why?
|
Optic Nerve | 1 | 2024 | 572 | 0.710 |
Why?
|
Craniotomy | 6 | 2020 | 741 | 0.700 |
Why?
|
Cranial Nerve Neoplasms | 4 | 2022 | 134 | 0.680 |
Why?
|
Magnetic Resonance Imaging | 34 | 2024 | 36426 | 0.660 |
Why?
|
Pituitary Apoplexy | 2 | 2016 | 29 | 0.610 |
Why?
|
Clothing | 1 | 2018 | 97 | 0.580 |
Why?
|
DNA Copy Number Variations | 7 | 2017 | 2020 | 0.580 |
Why?
|
Psychophysics | 1 | 2018 | 292 | 0.570 |
Why?
|
Neoplasm Recurrence, Local | 19 | 2024 | 9280 | 0.570 |
Why?
|
Mutation | 31 | 2024 | 30053 | 0.560 |
Why?
|
Humans | 163 | 2024 | 761596 | 0.520 |
Why?
|
Patient Transfer | 1 | 2023 | 794 | 0.520 |
Why?
|
Elasticity | 1 | 2018 | 655 | 0.520 |
Why?
|
Acromegaly | 2 | 2021 | 310 | 0.520 |
Why?
|
Labyrinth Diseases | 1 | 2017 | 151 | 0.500 |
Why?
|
Skull Base | 5 | 2024 | 292 | 0.500 |
Why?
|
Semicircular Canals | 1 | 2017 | 203 | 0.490 |
Why?
|
Neurilemmoma | 4 | 2022 | 526 | 0.490 |
Why?
|
Cerebellar Neoplasms | 3 | 2015 | 586 | 0.480 |
Why?
|
Chromosomes, Human | 1 | 2016 | 441 | 0.470 |
Why?
|
Motion Perception | 1 | 2018 | 374 | 0.470 |
Why?
|
Isocitrate Dehydrogenase | 8 | 2024 | 938 | 0.470 |
Why?
|
Cerebral Veins | 1 | 2015 | 157 | 0.450 |
Why?
|
Tomography, Spiral Computed | 1 | 2015 | 273 | 0.440 |
Why?
|
Cerebral Angiography | 2 | 2018 | 1281 | 0.430 |
Why?
|
Histones | 1 | 2023 | 2580 | 0.420 |
Why?
|
Cerebral Arteries | 1 | 2015 | 490 | 0.410 |
Why?
|
Artificial Intelligence | 3 | 2024 | 2578 | 0.400 |
Why?
|
Prognosis | 23 | 2024 | 29629 | 0.400 |
Why?
|
Cranial Irradiation | 3 | 2023 | 390 | 0.390 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2021 | 8554 | 0.390 |
Why?
|
Nervous System Diseases | 2 | 2021 | 1667 | 0.390 |
Why?
|
Methionine | 1 | 2014 | 572 | 0.380 |
Why?
|
Length of Stay | 2 | 2024 | 6426 | 0.370 |
Why?
|
Monitoring, Intraoperative | 2 | 2016 | 942 | 0.370 |
Why?
|
Hospitals | 2 | 2024 | 3883 | 0.370 |
Why?
|
Facial Nerve | 4 | 2023 | 277 | 0.360 |
Why?
|
Hospital Mortality | 1 | 2024 | 5293 | 0.350 |
Why?
|
Necrosis | 3 | 2023 | 1611 | 0.350 |
Why?
|
Retrospective Studies | 38 | 2024 | 80647 | 0.340 |
Why?
|
Preoperative Care | 3 | 2019 | 2242 | 0.340 |
Why?
|
Diffusion Tensor Imaging | 2 | 2024 | 2400 | 0.320 |
Why?
|
Tumor Burden | 6 | 2020 | 1892 | 0.320 |
Why?
|
Patient Readmission | 2 | 2020 | 3271 | 0.320 |
Why?
|
Diagnostic Imaging | 2 | 2023 | 3530 | 0.320 |
Why?
|
Insurance Coverage | 1 | 2020 | 1940 | 0.320 |
Why?
|
Surgery, Computer-Assisted | 2 | 2013 | 1007 | 0.310 |
Why?
|
Genomics | 9 | 2024 | 5821 | 0.300 |
Why?
|
Insurance, Health | 1 | 2020 | 2499 | 0.300 |
Why?
|
Teratoma | 2 | 2015 | 404 | 0.300 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2023 | 5314 | 0.290 |
Why?
|
Combined Modality Therapy | 11 | 2023 | 8527 | 0.280 |
Why?
|
Male | 69 | 2024 | 360846 | 0.280 |
Why?
|
Hematoma, Subdural, Chronic | 2 | 2020 | 95 | 0.280 |
Why?
|
Ubiquitin Thiolesterase | 3 | 2024 | 455 | 0.280 |
Why?
|
Neuronavigation | 4 | 2024 | 166 | 0.270 |
Why?
|
Paraneoplastic Polyneuropathy | 1 | 2006 | 2 | 0.270 |
Why?
|
MELAS Syndrome | 1 | 2006 | 56 | 0.270 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13642 | 0.260 |
Why?
|
Adenoma, Oxyphilic | 2 | 2018 | 148 | 0.260 |
Why?
|
Mixed Tumor, Mullerian | 1 | 2006 | 55 | 0.260 |
Why?
|
Astrocytoma | 3 | 2023 | 775 | 0.260 |
Why?
|
Adult | 51 | 2024 | 221210 | 0.250 |
Why?
|
Female | 63 | 2024 | 392705 | 0.240 |
Why?
|
Middle Aged | 53 | 2024 | 220921 | 0.240 |
Why?
|
Immunotherapy | 5 | 2023 | 4652 | 0.240 |
Why?
|
Hematologic Neoplasms | 1 | 2016 | 1896 | 0.230 |
Why?
|
DNA Mutational Analysis | 9 | 2017 | 4111 | 0.230 |
Why?
|
Neuroendoscopy | 2 | 2016 | 99 | 0.230 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2650 | 0.230 |
Why?
|
Rhabdoid Tumor | 2 | 2017 | 210 | 0.230 |
Why?
|
Brain Abscess | 2 | 2015 | 120 | 0.230 |
Why?
|
Sella Turcica | 2 | 2015 | 118 | 0.230 |
Why?
|
Geniculate Bodies | 1 | 2024 | 160 | 0.220 |
Why?
|
Telomerase | 2 | 2021 | 745 | 0.220 |
Why?
|
Hospitalization | 1 | 2023 | 10721 | 0.220 |
Why?
|
Internship and Residency | 1 | 2023 | 5882 | 0.220 |
Why?
|
Epigenesis, Genetic | 2 | 2016 | 3801 | 0.210 |
Why?
|
Ganglia, Spinal | 1 | 2006 | 526 | 0.210 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2021 | 2057 | 0.210 |
Why?
|
Pharmacology | 1 | 2003 | 100 | 0.210 |
Why?
|
Dura Mater | 2 | 2024 | 290 | 0.210 |
Why?
|
Tissue Adhesives | 1 | 2024 | 173 | 0.200 |
Why?
|
Brain | 11 | 2024 | 27121 | 0.200 |
Why?
|
Frozen Sections | 1 | 2002 | 153 | 0.200 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2002 | 427 | 0.200 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2024 | 9001 | 0.190 |
Why?
|
Pituitary Gland | 2 | 2015 | 635 | 0.190 |
Why?
|
Neoplasm Seeding | 2 | 2019 | 85 | 0.190 |
Why?
|
PTEN Phosphohydrolase | 4 | 2021 | 1115 | 0.190 |
Why?
|
Aged | 34 | 2024 | 169310 | 0.190 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13381 | 0.180 |
Why?
|
Gene Dosage | 4 | 2017 | 1218 | 0.180 |
Why?
|
Visual Pathways | 1 | 2024 | 551 | 0.180 |
Why?
|
Comparative Genomic Hybridization | 6 | 2017 | 473 | 0.180 |
Why?
|
Neurofibromin 1 | 1 | 2021 | 190 | 0.170 |
Why?
|
Cerebellopontine Angle | 2 | 2021 | 53 | 0.170 |
Why?
|
GATA2 Transcription Factor | 1 | 2020 | 158 | 0.170 |
Why?
|
Nitric Oxide Synthase | 1 | 2002 | 908 | 0.170 |
Why?
|
Pneumocephalus | 1 | 2020 | 47 | 0.170 |
Why?
|
Biology | 1 | 2022 | 290 | 0.170 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2005 | 491 | 0.170 |
Why?
|
Laminectomy | 2 | 2018 | 225 | 0.170 |
Why?
|
Oncolytic Viruses | 1 | 2023 | 344 | 0.170 |
Why?
|
Solitary Fibrous Tumors | 1 | 2020 | 67 | 0.170 |
Why?
|
Nitriles | 1 | 2024 | 971 | 0.170 |
Why?
|
Facial Paralysis | 1 | 2023 | 346 | 0.170 |
Why?
|
Co-Repressor Proteins | 1 | 2020 | 190 | 0.160 |
Why?
|
Pyridones | 1 | 2024 | 809 | 0.160 |
Why?
|
Cranial Sinuses | 1 | 2019 | 68 | 0.160 |
Why?
|
Multilingualism | 1 | 2020 | 87 | 0.160 |
Why?
|
Pneumatosis Cystoides Intestinalis | 1 | 2019 | 31 | 0.160 |
Why?
|
Treatment Outcome | 18 | 2024 | 64685 | 0.160 |
Why?
|
Chromosome Aberrations | 2 | 2016 | 1768 | 0.160 |
Why?
|
Salvage Therapy | 3 | 2019 | 1263 | 0.160 |
Why?
|
Postoperative Complications | 10 | 2023 | 15633 | 0.160 |
Why?
|
Molecular Targeted Therapy | 3 | 2019 | 2811 | 0.160 |
Why?
|
Hydrogels | 1 | 2024 | 720 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 698 | 0.150 |
Why?
|
Pituitary ACTH Hypersecretion | 1 | 2021 | 179 | 0.150 |
Why?
|
Collateral Circulation | 1 | 2019 | 294 | 0.150 |
Why?
|
Phlebography | 2 | 2019 | 326 | 0.150 |
Why?
|
Herpesvirus 1, Human | 1 | 2023 | 753 | 0.150 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3878 | 0.150 |
Why?
|
Interneurons | 1 | 2002 | 593 | 0.150 |
Why?
|
Oncolytic Virotherapy | 1 | 2023 | 516 | 0.150 |
Why?
|
Decompression, Surgical | 3 | 2018 | 607 | 0.150 |
Why?
|
Genome, Human | 4 | 2020 | 4425 | 0.140 |
Why?
|
Syringomyelia | 1 | 2018 | 67 | 0.140 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2002 | 895 | 0.140 |
Why?
|
Databases, Factual | 2 | 2024 | 7968 | 0.140 |
Why?
|
Tumor Suppressor Proteins | 2 | 2018 | 2805 | 0.140 |
Why?
|
Endoscopy | 3 | 2016 | 1851 | 0.140 |
Why?
|
Cell Separation | 1 | 2002 | 1720 | 0.140 |
Why?
|
DNA Methylation | 4 | 2024 | 4399 | 0.140 |
Why?
|
Nerve Tissue Proteins | 3 | 2007 | 4415 | 0.140 |
Why?
|
Uterine Neoplasms | 1 | 2006 | 1420 | 0.140 |
Why?
|
Prospective Studies | 6 | 2023 | 54423 | 0.140 |
Why?
|
Gonadotrophs | 1 | 2016 | 19 | 0.140 |
Why?
|
Neoplasms, Second Primary | 1 | 2005 | 1052 | 0.140 |
Why?
|
Cell Lineage | 2 | 2017 | 2557 | 0.140 |
Why?
|
Cohort Studies | 9 | 2024 | 41495 | 0.140 |
Why?
|
Brevican | 2 | 2014 | 5 | 0.140 |
Why?
|
Neurofibromatoses | 1 | 2020 | 299 | 0.140 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2018 | 150 | 0.140 |
Why?
|
Chromogranins | 1 | 2017 | 161 | 0.140 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2021 | 2917 | 0.140 |
Why?
|
Young Adult | 19 | 2024 | 59260 | 0.130 |
Why?
|
Hematoma, Subdural, Acute | 1 | 2016 | 16 | 0.130 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2016 | 42 | 0.130 |
Why?
|
Sphenoid Sinus | 1 | 2016 | 99 | 0.130 |
Why?
|
Arnold-Chiari Malformation | 1 | 2018 | 158 | 0.130 |
Why?
|
Ear Neoplasms | 1 | 2016 | 118 | 0.130 |
Why?
|
Medical Oncology | 2 | 2024 | 2321 | 0.130 |
Why?
|
World Health Organization | 1 | 2022 | 1322 | 0.130 |
Why?
|
American Civil War | 1 | 2015 | 8 | 0.130 |
Why?
|
Neural Tube Defects | 1 | 2018 | 255 | 0.130 |
Why?
|
Hyponatremia | 1 | 2018 | 279 | 0.130 |
Why?
|
Ganglioglioma | 1 | 2015 | 36 | 0.130 |
Why?
|
INDEL Mutation | 1 | 2016 | 266 | 0.130 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 195 | 0.130 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2018 | 727 | 0.130 |
Why?
|
Endocrine Surgical Procedures | 1 | 2015 | 32 | 0.130 |
Why?
|
Psychosurgery | 1 | 2015 | 86 | 0.120 |
Why?
|
Molecular Chaperones | 1 | 2020 | 754 | 0.120 |
Why?
|
Pinealoma | 1 | 2015 | 52 | 0.120 |
Why?
|
Chordoma | 1 | 2018 | 347 | 0.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2022 | 3639 | 0.120 |
Why?
|
DNA, Neoplasm | 2 | 2017 | 1745 | 0.120 |
Why?
|
Odontoid Process | 1 | 2015 | 46 | 0.120 |
Why?
|
Infratentorial Neoplasms | 1 | 2015 | 98 | 0.120 |
Why?
|
Rhizopus | 1 | 2014 | 22 | 0.120 |
Why?
|
Fluorescent Dyes | 1 | 2002 | 1903 | 0.120 |
Why?
|
Pituitary Diseases | 1 | 2015 | 135 | 0.120 |
Why?
|
Vestibule, Labyrinth | 1 | 2016 | 234 | 0.120 |
Why?
|
Famous Persons | 1 | 2015 | 109 | 0.120 |
Why?
|
Medicine | 1 | 2003 | 942 | 0.120 |
Why?
|
Baseball | 1 | 2015 | 95 | 0.120 |
Why?
|
Transcription Factors | 5 | 2024 | 12130 | 0.120 |
Why?
|
Skull Neoplasms | 1 | 2015 | 173 | 0.110 |
Why?
|
Head Protective Devices | 1 | 2015 | 118 | 0.110 |
Why?
|
Follow-Up Studies | 9 | 2024 | 39106 | 0.110 |
Why?
|
Endopeptidases | 1 | 2018 | 774 | 0.110 |
Why?
|
Liability, Legal | 1 | 2015 | 210 | 0.110 |
Why?
|
Melanoma | 3 | 2022 | 5709 | 0.110 |
Why?
|
Epidural Space | 1 | 2015 | 122 | 0.110 |
Why?
|
Basal Ganglia Diseases | 1 | 2014 | 145 | 0.110 |
Why?
|
Gene Expression Profiling | 5 | 2023 | 9420 | 0.110 |
Why?
|
Meningitis, Bacterial | 1 | 2016 | 221 | 0.110 |
Why?
|
History, 20th Century | 5 | 2022 | 2767 | 0.110 |
Why?
|
Telomere | 1 | 2020 | 943 | 0.110 |
Why?
|
Diskectomy | 1 | 2015 | 209 | 0.110 |
Why?
|
Angiography, Digital Subtraction | 1 | 2015 | 335 | 0.110 |
Why?
|
Semantics | 1 | 2017 | 613 | 0.110 |
Why?
|
Epidural Abscess | 1 | 2015 | 94 | 0.110 |
Why?
|
Medulla Oblongata | 1 | 2015 | 248 | 0.110 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 6075 | 0.110 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2014 | 386 | 0.110 |
Why?
|
Mucormycosis | 1 | 2014 | 103 | 0.110 |
Why?
|
Functional Laterality | 1 | 2020 | 2257 | 0.110 |
Why?
|
Military Personnel | 1 | 2022 | 1246 | 0.110 |
Why?
|
Oligodendroglioma | 1 | 2014 | 279 | 0.100 |
Why?
|
Video Recording | 1 | 2018 | 967 | 0.100 |
Why?
|
Neoplasms | 2 | 2019 | 22173 | 0.100 |
Why?
|
Morbidity | 1 | 2018 | 1752 | 0.100 |
Why?
|
Hydrocortisone | 1 | 2021 | 1819 | 0.100 |
Why?
|
Ependymoma | 1 | 2016 | 320 | 0.100 |
Why?
|
beta Catenin | 1 | 2018 | 1040 | 0.100 |
Why?
|
Radiation Injuries | 1 | 2020 | 1189 | 0.100 |
Why?
|
Microsurgery | 2 | 2015 | 795 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2022 | 1303 | 0.100 |
Why?
|
Aged, 80 and over | 13 | 2020 | 58984 | 0.100 |
Why?
|
Scalp | 1 | 2015 | 389 | 0.100 |
Why?
|
Nuclear Proteins | 4 | 2024 | 5799 | 0.100 |
Why?
|
Social Class | 1 | 2021 | 2004 | 0.100 |
Why?
|
Brachytherapy | 1 | 2019 | 1223 | 0.100 |
Why?
|
Disease Progression | 8 | 2019 | 13510 | 0.100 |
Why?
|
Survival Rate | 7 | 2024 | 12723 | 0.100 |
Why?
|
RNA, Messenger | 3 | 2017 | 12794 | 0.100 |
Why?
|
Regional Blood Flow | 1 | 2015 | 1496 | 0.100 |
Why?
|
Oncogenes | 1 | 2017 | 1222 | 0.100 |
Why?
|
Massachusetts | 1 | 2024 | 8833 | 0.090 |
Why?
|
Postoperative Period | 3 | 2021 | 1814 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3492 | 0.090 |
Why?
|
Antibiotic Prophylaxis | 1 | 2016 | 637 | 0.090 |
Why?
|
Malpractice | 1 | 2015 | 556 | 0.090 |
Why?
|
Cell Line, Tumor | 7 | 2022 | 16990 | 0.090 |
Why?
|
Language | 1 | 2020 | 1543 | 0.090 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2017 | 1651 | 0.090 |
Why?
|
Patient Discharge | 1 | 2023 | 3443 | 0.090 |
Why?
|
Curriculum | 1 | 2023 | 3743 | 0.090 |
Why?
|
Spinal Neoplasms | 1 | 2016 | 716 | 0.090 |
Why?
|
Radionuclide Imaging | 1 | 2014 | 1972 | 0.090 |
Why?
|
Societies, Medical | 1 | 2022 | 3905 | 0.090 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2016 | 617 | 0.080 |
Why?
|
Adolescent | 15 | 2024 | 88326 | 0.080 |
Why?
|
SEER Program | 3 | 2022 | 1450 | 0.080 |
Why?
|
Neurofibromin 2 | 2 | 2023 | 271 | 0.080 |
Why?
|
Child, Preschool | 6 | 2024 | 42232 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1486 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2019 | 3359 | 0.080 |
Why?
|
Mutation, Missense | 1 | 2018 | 2571 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1866 | 0.080 |
Why?
|
Animals | 14 | 2024 | 168475 | 0.080 |
Why?
|
Brain Diseases | 1 | 2018 | 1546 | 0.080 |
Why?
|
Algorithms | 3 | 2019 | 14033 | 0.080 |
Why?
|
Evolution, Molecular | 1 | 2017 | 1886 | 0.080 |
Why?
|
Pulmonary Embolism | 1 | 2022 | 2567 | 0.080 |
Why?
|
Epilepsy | 1 | 2024 | 3290 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1745 | 0.080 |
Why?
|
Ultrasonography | 2 | 2024 | 5971 | 0.080 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2016 | 954 | 0.080 |
Why?
|
Cerebral Cortex | 2 | 2019 | 5779 | 0.070 |
Why?
|
Clinical Competence | 1 | 2023 | 4793 | 0.070 |
Why?
|
Spine | 1 | 2015 | 1118 | 0.070 |
Why?
|
Seizures | 3 | 2024 | 2957 | 0.070 |
Why?
|
Medicaid | 1 | 2020 | 2818 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2022 | 8002 | 0.070 |
Why?
|
Sequence Analysis, DNA | 4 | 2020 | 4740 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 4 | 2024 | 20568 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2865 | 0.070 |
Why?
|
Neoplastic Stem Cells | 1 | 2014 | 1351 | 0.070 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4915 | 0.070 |
Why?
|
Health Care Reform | 1 | 2015 | 1247 | 0.070 |
Why?
|
Reproducibility of Results | 5 | 2024 | 20100 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2016 | 12690 | 0.070 |
Why?
|
Recovery of Function | 1 | 2016 | 2979 | 0.070 |
Why?
|
United States | 8 | 2022 | 72340 | 0.070 |
Why?
|
Neoadjuvant Therapy | 1 | 2017 | 2828 | 0.060 |
Why?
|
Macrophages | 1 | 2020 | 5767 | 0.060 |
Why?
|
DNA-Binding Proteins | 3 | 2018 | 9610 | 0.060 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2007 | 247 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2015 | 2827 | 0.060 |
Why?
|
Arachnoid Cysts | 1 | 2006 | 61 | 0.060 |
Why?
|
Preoperative Period | 2 | 2018 | 551 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26129 | 0.060 |
Why?
|
Hemianopsia | 1 | 2006 | 121 | 0.060 |
Why?
|
Remission Induction | 2 | 2021 | 2397 | 0.060 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2006 | 188 | 0.060 |
Why?
|
DNA Helicases | 2 | 2024 | 851 | 0.060 |
Why?
|
Brain Mapping | 1 | 2020 | 6635 | 0.060 |
Why?
|
Ascites | 1 | 2006 | 338 | 0.060 |
Why?
|
Brain Concussion | 1 | 2015 | 1404 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11742 | 0.060 |
Why?
|
Gene Expression | 1 | 2016 | 7581 | 0.060 |
Why?
|
Consensus | 2 | 2024 | 3124 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2022 | 5672 | 0.060 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2019 | 1784 | 0.060 |
Why?
|
Basal Ganglia | 1 | 2006 | 554 | 0.060 |
Why?
|
Survivors | 1 | 2014 | 2371 | 0.060 |
Why?
|
Emergency Service, Hospital | 1 | 2023 | 7879 | 0.050 |
Why?
|
Equipment Failure | 1 | 2006 | 578 | 0.050 |
Why?
|
Brain Injuries | 1 | 2015 | 2054 | 0.050 |
Why?
|
Receptors, AMPA | 1 | 2024 | 336 | 0.050 |
Why?
|
Korean War | 1 | 2022 | 6 | 0.050 |
Why?
|
History, 19th Century | 2 | 2015 | 720 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2017 | 3980 | 0.050 |
Why?
|
Child | 9 | 2024 | 80158 | 0.050 |
Why?
|
Carbocyanines | 1 | 2002 | 175 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2015 | 2492 | 0.050 |
Why?
|
Rhodamines | 1 | 2002 | 178 | 0.050 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2002 | 174 | 0.050 |
Why?
|
Postoperative Care | 2 | 2019 | 1468 | 0.050 |
Why?
|
Vestibulocochlear Nerve | 1 | 2021 | 115 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2021 | 15266 | 0.050 |
Why?
|
Atrophy | 1 | 2006 | 1633 | 0.050 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2023 | 506 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7391 | 0.050 |
Why?
|
Genetic Testing | 1 | 2014 | 3537 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 9177 | 0.050 |
Why?
|
Computer Systems | 1 | 2002 | 470 | 0.050 |
Why?
|
Hydrazines | 1 | 2002 | 224 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2020 | 3605 | 0.050 |
Why?
|
Calibration | 1 | 2023 | 818 | 0.050 |
Why?
|
Neoplasm, Residual | 2 | 2016 | 1008 | 0.040 |
Why?
|
Subdural Space | 1 | 2020 | 38 | 0.040 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 1 | 2021 | 63 | 0.040 |
Why?
|
Incidence | 4 | 2022 | 21355 | 0.040 |
Why?
|
Huntington Disease | 1 | 2007 | 1144 | 0.040 |
Why?
|
Sagittal Sinus Thrombosis | 1 | 2019 | 11 | 0.040 |
Why?
|
Age Factors | 3 | 2024 | 18399 | 0.040 |
Why?
|
Lateral Sinus Thrombosis | 1 | 2019 | 7 | 0.040 |
Why?
|
Ultrasonography, Doppler | 1 | 2022 | 462 | 0.040 |
Why?
|
Immunohistochemistry | 3 | 2021 | 11076 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14665 | 0.040 |
Why?
|
Reference Standards | 1 | 2023 | 1003 | 0.040 |
Why?
|
Reoperation | 3 | 2018 | 4303 | 0.040 |
Why?
|
Interleukin-12 | 1 | 2022 | 584 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 1 | 2015 | 3763 | 0.040 |
Why?
|
Cognition | 1 | 2017 | 6992 | 0.040 |
Why?
|
Unemployment | 1 | 2021 | 210 | 0.040 |
Why?
|
Pathology, Molecular | 1 | 2022 | 328 | 0.040 |
Why?
|
Genetic Markers | 2 | 2015 | 2601 | 0.040 |
Why?
|
New England | 1 | 2022 | 1054 | 0.040 |
Why?
|
Random Allocation | 1 | 2023 | 2395 | 0.040 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2021 | 618 | 0.040 |
Why?
|
Geography | 1 | 2021 | 656 | 0.040 |
Why?
|
Lasers | 1 | 2002 | 952 | 0.040 |
Why?
|
Syndrome | 1 | 2005 | 3267 | 0.040 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2018 | 145 | 0.040 |
Why?
|
Isoenzymes | 1 | 2002 | 1687 | 0.040 |
Why?
|
Specimen Handling | 1 | 2002 | 702 | 0.040 |
Why?
|
Ecosystem | 1 | 2022 | 490 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2017 | 2457 | 0.040 |
Why?
|
Survival Analysis | 2 | 2023 | 10090 | 0.040 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2019 | 350 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2020 | 784 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2022 | 634 | 0.040 |
Why?
|
Signal Transduction | 2 | 2018 | 23447 | 0.040 |
Why?
|
Head | 1 | 2023 | 924 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 250 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4580 | 0.040 |
Why?
|
Face | 1 | 2023 | 1026 | 0.040 |
Why?
|
Pilot Projects | 2 | 2024 | 8633 | 0.040 |
Why?
|
Cerebellar Diseases | 1 | 2019 | 220 | 0.040 |
Why?
|
Brain Infarction | 1 | 2019 | 290 | 0.040 |
Why?
|
Mice | 6 | 2022 | 81539 | 0.040 |
Why?
|
Automation | 1 | 2019 | 586 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 428 | 0.030 |
Why?
|
Hypophysectomy | 1 | 2016 | 114 | 0.030 |
Why?
|
Central Nervous System | 1 | 2024 | 1336 | 0.030 |
Why?
|
Mammals | 1 | 2022 | 1132 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2019 | 638 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2020 | 2016 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2006 | 3769 | 0.030 |
Why?
|
Corpus Striatum | 1 | 2002 | 1235 | 0.030 |
Why?
|
Limit of Detection | 1 | 2017 | 273 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 617 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1232 | 0.030 |
Why?
|
Cell Tracking | 1 | 2017 | 139 | 0.030 |
Why?
|
History, 21st Century | 1 | 2022 | 1567 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 615 | 0.030 |
Why?
|
Phenotype | 3 | 2020 | 16592 | 0.030 |
Why?
|
Mental Disorders | 1 | 2015 | 6845 | 0.030 |
Why?
|
Verbal Behavior | 1 | 2017 | 335 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5821 | 0.030 |
Why?
|
Cranial Nerve Injuries | 1 | 2015 | 28 | 0.030 |
Why?
|
Medically Uninsured | 1 | 2021 | 836 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2020 | 1869 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2016 | 510 | 0.030 |
Why?
|
Head Injuries, Penetrating | 1 | 2015 | 28 | 0.030 |
Why?
|
Rats | 3 | 2014 | 23741 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2330 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2020 | 1229 | 0.030 |
Why?
|
Risk Factors | 5 | 2022 | 74213 | 0.030 |
Why?
|
Cadaver | 1 | 2019 | 1358 | 0.030 |
Why?
|
Sphenoid Bone | 1 | 2016 | 177 | 0.030 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2016 | 305 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 3 | 2018 | 17904 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2024 | 1906 | 0.030 |
Why?
|
Health Resources | 1 | 2021 | 935 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2006 | 2791 | 0.030 |
Why?
|
Trigeminal Nerve Diseases | 1 | 2015 | 49 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1092 | 0.030 |
Why?
|
Follicle Stimulating Hormone | 1 | 2016 | 726 | 0.030 |
Why?
|
Pineal Gland | 1 | 2015 | 158 | 0.030 |
Why?
|
Biopsy | 2 | 2017 | 6766 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 2 | 2019 | 4062 | 0.030 |
Why?
|
Cell Survival | 2 | 2014 | 5791 | 0.030 |
Why?
|
Pons | 1 | 2015 | 240 | 0.030 |
Why?
|
Swine | 1 | 2024 | 5915 | 0.030 |
Why?
|
RNA, Neoplasm | 1 | 2016 | 750 | 0.030 |
Why?
|
Retina | 1 | 2024 | 2659 | 0.030 |
Why?
|
Gene Fusion | 1 | 2016 | 356 | 0.030 |
Why?
|
Therapeutic Irrigation | 1 | 2015 | 292 | 0.030 |
Why?
|
Clone Cells | 1 | 2017 | 1659 | 0.030 |
Why?
|
Educational Status | 1 | 2021 | 2522 | 0.030 |
Why?
|
Steroids | 1 | 2018 | 929 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2643 | 0.030 |
Why?
|
Brain Stem Neoplasms | 1 | 2015 | 190 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3606 | 0.030 |
Why?
|
Wakefulness | 1 | 2020 | 1265 | 0.030 |
Why?
|
Observer Variation | 1 | 2019 | 2606 | 0.030 |
Why?
|
Leadership | 1 | 2022 | 1385 | 0.030 |
Why?
|
Rats, Inbred Lew | 1 | 2014 | 1157 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2024 | 3449 | 0.030 |
Why?
|
Surgical Instruments | 1 | 2015 | 383 | 0.030 |
Why?
|
Homicide | 1 | 2015 | 294 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2018 | 909 | 0.030 |
Why?
|
Income | 1 | 2021 | 1877 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2015 | 916 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2016 | 1827 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2019 | 1432 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2005 | 4937 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2018 | 10451 | 0.020 |
Why?
|
Area Under Curve | 1 | 2016 | 1638 | 0.020 |
Why?
|
Mice, Nude | 1 | 2018 | 3614 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 899 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2002 | 8181 | 0.020 |
Why?
|
Mice, SCID | 1 | 2016 | 2626 | 0.020 |
Why?
|
Serine Endopeptidases | 1 | 2016 | 1023 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2020 | 2302 | 0.020 |
Why?
|
Nose | 1 | 2015 | 521 | 0.020 |
Why?
|
Hearing | 1 | 2015 | 501 | 0.020 |
Why?
|
Genotype | 2 | 2016 | 12990 | 0.020 |
Why?
|
Cerebrovascular Disorders | 1 | 2018 | 1474 | 0.020 |
Why?
|
Infant | 3 | 2018 | 36193 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2015 | 1386 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2961 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 2919 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3597 | 0.020 |
Why?
|
Drainage | 1 | 2015 | 1157 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2013 | 1574 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 12973 | 0.020 |
Why?
|
Visual Fields | 1 | 2016 | 1062 | 0.020 |
Why?
|
Intracranial Hemorrhages | 1 | 2015 | 822 | 0.020 |
Why?
|
Autophagy | 1 | 2017 | 1327 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2014 | 1835 | 0.020 |
Why?
|
Wounds, Gunshot | 1 | 2015 | 582 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2021 | 2576 | 0.020 |
Why?
|
Poverty | 1 | 2021 | 2697 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2022 | 3600 | 0.020 |
Why?
|
Gene Silencing | 1 | 2015 | 1509 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2017 | 1858 | 0.020 |
Why?
|
Exons | 1 | 2014 | 2391 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 2021 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 2057 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8466 | 0.020 |
Why?
|
Time Factors | 2 | 2016 | 39969 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6484 | 0.020 |
Why?
|
Cerebellum | 1 | 2015 | 1501 | 0.020 |
Why?
|
Temporal Lobe | 1 | 2015 | 1695 | 0.020 |
Why?
|
Phosphorylation | 1 | 2018 | 8321 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2016 | 7406 | 0.020 |
Why?
|
Memory | 1 | 2017 | 2193 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7828 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3514 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2014 | 6131 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2014 | 1726 | 0.020 |
Why?
|
Attention | 1 | 2017 | 2396 | 0.020 |
Why?
|
Anticoagulants | 1 | 2022 | 4812 | 0.020 |
Why?
|
Cell Movement | 1 | 2018 | 5205 | 0.020 |
Why?
|
Mice, Inbred DBA | 1 | 2007 | 621 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10194 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6815 | 0.020 |
Why?
|
Twins, Monozygotic | 1 | 2007 | 470 | 0.020 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2005 | 141 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3430 | 0.020 |
Why?
|
Diseases in Twins | 1 | 2007 | 446 | 0.020 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 2006 | 195 | 0.010 |
Why?
|
Ventriculostomy | 1 | 2006 | 131 | 0.010 |
Why?
|
Computational Biology | 1 | 2016 | 3517 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5790 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14608 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2007 | 2264 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3802 | 0.010 |
Why?
|
Genomic Instability | 1 | 2007 | 709 | 0.010 |
Why?
|
DNA Primers | 1 | 2007 | 2820 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 3201 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9327 | 0.010 |
Why?
|
Critical Care | 1 | 2015 | 2697 | 0.010 |
Why?
|
Glycosylation | 1 | 2005 | 1097 | 0.010 |
Why?
|
Lectins, C-Type | 1 | 2005 | 585 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5305 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22174 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2006 | 1186 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12463 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11120 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2005 | 1699 | 0.010 |
Why?
|
Heart Atria | 1 | 2006 | 1345 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2015 | 4024 | 0.010 |
Why?
|
Visual Cortex | 1 | 2007 | 1108 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10212 | 0.010 |
Why?
|
Pediatrics | 1 | 2014 | 3589 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 26202 | 0.010 |
Why?
|
Apoptosis | 1 | 2014 | 9490 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 15936 | 0.010 |
Why?
|
Transfection | 1 | 2005 | 5774 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2014 | 11530 | 0.010 |
Why?
|
Base Sequence | 1 | 2007 | 12441 | 0.010 |
Why?
|
Cell Membrane | 1 | 2005 | 3687 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2007 | 9542 | 0.010 |
Why?
|
Neurons | 1 | 2007 | 9463 | 0.000 |
Why?
|